| Extracellular vesicles including exosomes regulate innate immune responses to hepatitis B virus infection T Kouwaki, Y Fukushima, T Daito, T Sanada, N Yamamoto, EJ Mifsud, ... Frontiers in Immunology 7, 335, 2016 | 183 | 2016 |
| TLR agonists as modulators of the innate immune response and their potential as agents against infectious disease EJ Mifsud, ACL Tan, DC Jackson Frontiers in immunology 5, 79, 2014 | 169 | 2014 |
| Antivirals targeting the polymerase complex of influenza viruses EJ Mifsud, FG Hayden, AC Hurt Antiviral research 169, 104545, 2019 | 154 | 2019 |
| Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in mice ACL Tan, EJ Mifsud, W Zeng, K Edenborough, J McVernon, LE Brown, ... Molecular pharmaceutics 9 (9), 2710-2718, 2012 | 120 | 2012 |
| Tear interferon-gamma as a biomarker for evaporative dry eye disease DC Jackson, W Zeng, CY Wong, EJ Mifsud, NA Williamson, CS Ang, ... Investigative ophthalmology & visual science 57 (11), 4824-4830, 2016 | 86 | 2016 |
| Diabetes and overweight/obesity are independent, nonadditive risk factors for in-hospital severity of COVID-19: an international, multicenter retrospective meta-analysis DK Longmore, JE Miller, S Bekkering, C Saner, E Mifsud, Y Zhu, R Saffery, ... Diabetes Care 44 (6), 1281-1290, 2021 | 81 | 2021 |
| Innate immune responses to influenza virus infections in the upper respiratory tract EJ Mifsud, M Kuba, IG Barr Viruses 13 (10), 2090, 2021 | 42 | 2021 |
| Inactivated influenza vaccine that provides rapid, innate-immune-system-mediated protection and subsequent long-term adaptive immunity BY Chua, CY Wong, EJ Mifsud, KM Edenborough, T Sekiya, ACL Tan, ... MBio 6 (6), 10.1128/mbio. 01024-15, 2015 | 40 | 2015 |
| Baloxavir treatment of ferrets infected with influenza A (H1N1) pdm09 virus reduces onward transmission LYY Lee, J Zhou, R Frise, DH Goldhill, P Koszalka, EJ Mifsud, K Baba, ... PLoS pathogens 16 (4), e1008395, 2020 | 31 | 2020 |
| Links between recognition and degradation of cytoplasmic viral RNA in innate immune response H Oshiumi, EJ Mifsud, T Daito Reviews in medical virology 26 (2), 90-101, 2016 | 27 | 2016 |
| Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model LY Lee, J Zhou, P Koszalka, R Frise, R Farrukee, K Baba, S Miah, ... PLoS pathogens 17 (5), e1009527, 2021 | 25 | 2021 |
| Prophylaxis of ferrets with nitazoxanide and oseltamivir combinations is more effective at reducing the impact of influenza a virus infection compared to oseltamivir monotherapy EJ Mifsud, D Tilmanis, DY Oh, CMK Tai, JF Rossignol, AC Hurt Antiviral research 176, 104751, 2020 | 25 | 2020 |
| Reducing the impact of influenza‐associated secondary pneumococcal infections EJ Mifsud, AC Tan, KR Short, LE Brown, BY Chua, DC Jackson Immunology and cell biology 94 (1), 101-108, 2016 | 22 | 2016 |
| Animal models used to assess influenza antivirals EJ Mifsud, CMK Tai, AC Hurt Expert Opinion on Drug Discovery 13 (12), 1131-1139, 2018 | 21 | 2018 |
| Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza T Sekiya, EJ Mifsud, M Ohno, N Nomura, M Sasada, D Fujikura, T Daito, ... Vaccine 37 (15), 2158-2166, 2019 | 18 | 2019 |
| A rapid pyrosequencing assay for the molecular detection of influenza viruses with reduced baloxavir susceptibility due to PA/I38X amino acid substitutions P Koszalka, R Farrukee, E Mifsud, D Vijaykrishna, AC Hurt Influenza and other respiratory viruses 14 (4), 460-464, 2020 | 13 | 2020 |
| Mapping the pulmonary environment of animals protected from virulent H1N1 influenza infection using the TLR‐2 agonist Pam2Cys EJ Mifsud, ACL Tan, PC Reading, DC Jackson Immunology and Cell Biology 94 (2), 169-176, 2016 | 13 | 2016 |
| Host-targeted nitazoxanide has a high barrier to resistance but does not reduce the emergence or proliferation of oseltamivir-resistant influenza viruses in vitro or in vivo … D Tilmanis, P Koszalka, IG Barr, JF Rossignol, E Mifsud, AC Hurt Antiviral Research 180, 104851, 2020 | 12 | 2020 |
| International BMI-COVID consortium. Diabetes and overweight/obesity are independent, nonadditive risk factors for in-hospital severity of COVID-19: An International … DK Longmore, JE Miller, S Bekkering, C Saner, E Mifsud, Y Zhu, R Saffery, ... Diabetes Care 44 (6), 1281-1290, 2021 | 10 | 2021 |
| Generation of adaptive immune responses following influenza virus challenge is not compromised by pre-treatment with the TLR-2 agonist Pam2Cys EJ Mifsud, ACL Tan, LE Brown, BYL Chua, DC Jackson Frontiers in Immunology 6, 148327, 2015 | 9 | 2015 |
